Dong, Kun, et al. “Efficacy and Safety of Regorafenib Versus Dinutuximab With Chemotherapy in Chinese Children With Neuroblastoma”. Bangladesh Journal of Pharmacology, vol. 14, no. 1, Feb. 2019, pp. 32-35, doi:10.3329/bjp.v14i1.38807.